HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC Enforcement Hangs Over Memory Product Firm After Overlooking NAD Review

This article was originally published in The Rose Sheet

Executive Summary

KNH Online did not respond to NAD's request for information supporting claims for its Adderin supplement, including the statement "clinically proven to sky-rocket concentration by 312%" and a customer testimonial that "it started working within minutes of taking it … I experienced a mental clarity that I’d never felt before."

Advertisement

Related Content

Cold Sore Ad Claims Review Poses Test For OTC Monograph Indications
GAO Memory Supplement Review Recalls FDA's Regulatory Challenges
Supplement Claims Targeting Elderly, Weight Conscious Top FTC Priorities
NAD Could Jog Cognitive Benefit Supplement Firm's Memory With FTC Call
Sports Nutrition Products Mark Start Of FDA’s Picamilon Enforcement

Topics

Advertisement
UsernamePublicRestriction

Register

RS109170

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel